Lifecycle
Expired
stage pending
Spin-off detail
12B/A - Atrium Therapeutics, Inc. -> SpinCo
n/a / n/a ยท detected 2026-02-17
Triage
Reject
REJECT_JUNK
Confidence
50%
detection/extraction
Listing
n/a
distribution n/a
Extracted thesis
Business The information required by this item is contained under the sections “Questions and Answers about the Separation and Distribution,”
Description of Registrant’s Securities to be Registered The information required by this item is contained under the sections “Questions and Answers about the Separation and Distribution,”
Indemnification of Directors and Officers The information required by this item is contained under the sections “The Separation and Distribution—The Separation Agreement—Indemnification,”
Non-Employee Director Compensation Program# 10.15 Form of Indemnification Agreement to be in effect following the Distribution 10.16 Amended and Restated Lease Agreement, dated December 18, 2020, by and between ARE-SD Region No.
THIRD: The nature of the business or purposes to be conducted or promoted by the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware.
Solely for purposes of this Article EIGHTH, “officer”
Risk flags
Operational dependency flags: transitional_services, related_party_agreements.
risk
Debt and capitalization disclosures are present and should be tracked.
risk
Estimated float is unavailable from current filing data.
risk
Source Links
3-Year Financials
Revenue by year
Operating income or ebit by year
Margin by year
Margin trend
Ownership and float
Total shares
Parent retained shares percent
Insider or management shares percent
Restricted or locked up shares
Estimated float percent
Assumption noteFloat estimate unavailable from filing text.
Management incentives
Management ownership percent
Equity comp alignment indicators["2 to FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 Atrium Therapeutics, Inc.", "2026 Incentive Award Plan, including forms of grant notices and agreements thereunder**# 10.6 Form of Make Whole Restricted Stock Unit Grant Notice and Make Whole Restricted Stock Unit Agreement under the Atrium Therapeutics, Inc.", "Certain exhibits and schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K."]
Parent to spinoff leadership migration